Cancer Image Gallery
Last 30 Uploads
The Ibrutinib drug is a kinase inhibitor that can do survival enhancement with diffuse large B-cell lymphoma observed in younger individuals. According to the findings published in Journal Cancer Cell, a new analysis by researchers at the USA’s National Cancer Institute conducted a phase-3 clinical trial.
Earlier patients with diffuse large B-cell lymphoma were treated with R-CHOP, but this therapy is not helpful for everyone with diffuse large B-cell lymphoma.
Ibrutinib inhibits the function of Bruton tyrosine kinase, a protein that helps in the growth and survival of B cells. Cancerous cells of the ‘active B cell-like’ (ABC) subtype of diffuse large B-cell lymphoma require this protein to survive.
Regorafenib is a tyrosine kinase inhibitor, used to treat cancer of the colon and rectum, liver cancer and a certain cancer of the digestive systems. The regorafenib price in India can vary. To get the price and procurement related deets, kindly contact us at TOLL-FREE Number: 1800-889-1064. Regorafenib should be taken with food, but taking it at the same time every day will offer the maximum benefits. A health specialist will specify what dose is apt and how often you need to administer it. Administering your dosage in the wrong way can cause very severe side effects. It may take several weeks or months for you to notice the benefits but do not interrupt taking this medication unless your health specialist tells you to.
Afatinib helps to treat and prevent the growth of non-small cell lung cancer. It falls under the group of drugs called a TKI which blocks the proteins that promote the growth of cancer cells. The afatinib cost is expected to vary due to the availability of both generic as well as innovator brands. Dial our TOLL-FREE Number: 1800-889-1064 to know the appropriate cost of afatinib. Afatinib comes as tablets and is to be administered on an empty stomach. Dose administration is determined by your health specialist. Afatinib pills are not recommended for use in patients with known allergies to it.
Plerixafor injection 24 mg/1.2 ml mainly is a hematopoietic stem cell mobilizer, helps bone marrow release stem cells in the bloodstream so they can be gathered and transplanted back into the body. The plerixafor injection 24 mg/1.2 ml is used in individuals with NHL (non-Hodgkin's lymphoma) or MM-multiple myeloma. Treatment with Plerixafor should be started after the patient has received G-CSF once daily for four days. Administer Plerixafor approximately 11 hours prior to initiation of each apheresis for up to 4 consecutive days. The recommended dosage of Plerixafor should be administered by subcutaneous injection and should be based on the body weight.
Add This Forum To Your Favorites!
Skeptical about Alternative Cancer Therapies? Have skeptical questions? Go to Cancer Debate Forum.
Forum Stats:
forum viewed 15,710,074 times
23,267 messages
4,972 topics
topics per page limited to: 5
average number of messages per page: 23
994 pages
CureZone Newsletter is distributed in partnership with www.netatlantic.com
Copyright 1999 - 2022 www.curezone.com